Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

C. difficile toxin binding polymer demonstrates tolerability in phase I trial

Sep. 4, 2000

FXR ligands synthesized by Glaxo Wellcome

Aug. 31, 2000

InKine changes trade name of Diacol to Visicol

Aug. 29, 2000

New compounds interacting with opioid receptors useful for IBS, etc.

Aug. 28, 2000

Omeprazole infusion reduces recurrent bleeding in peptic ulcer patients

Aug. 25, 2000

Fas gene highlighted in hepatitis research

Aug. 23, 2000

Salix receives milestone payment from Shire for balsalazide

Aug. 18, 2000

Innogenetics commences phase I trial of therapeutic hepatitis C vaccine

Aug. 18, 2000

New compounds interacting with 5-HT4 receptor useful for gastrointestinal disorders

Aug. 17, 2000

Novel cell adhesion antagonists described

Aug. 17, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...